Dongxing Zha

Company: Alloy Therapeutics

Job title: CTO, TCR Discovery & Engineering

Seminars:

The Novel Platform of Discovery and Engineering TCR Mimic Antibodies to Enhance Therapeutic Index of Efficacy and Safety 11:30 am

• Examining methods to engineer TCR mimic antibodies to magnify specificity for target antigens • Reviewing the pros and cons of affinity enhanced TCR mimic antibodies to safeguard patient safety • Escalating affinity to the target peptide as well as the MHC to optimize efficacyRead more

day: Day Two